Development of a chimeric Plasmodium berghei strain expressing the repeat region of the P. vivax circumsporozoite protein for in vivo evaluation of vaccine efficacy.
about
Malaria vaccines: identifying Plasmodium falciparum liver-stage targetsRational development of a protective P. vivax vaccine evaluated with transgenic rodent parasite challenge models.Baculovirus-vectored multistage Plasmodium vivax vaccine induces both protective and transmission-blocking immunities against transgenic rodent malaria parasites.The repeat region of the circumsporozoite protein is critical for sporozoite formation and maturation in Plasmodium.P. falciparum and P. vivax Epitope-Focused VLPs Elicit Sterile Immunity to Blood Stage Infections.Proteolytic Cleavage of the Plasmodium falciparum Circumsporozoite Protein Is a Target of Protective Antibodies.Quantitative characterization of hemozoin in Plasmodium berghei and vivax.Development of a Plasmodium berghei transgenic parasite expressing the full-length Plasmodium vivax circumsporozoite VK247 protein for testing vaccine efficacy in a murine modelImmunogenicity of a prime-boost vaccine containing the circumsporozoite proteins of Plasmodium vivax in rodents.Efficacy of a Plasmodium vivax malaria vaccine using ChAd63 and modified vaccinia Ankara expressing thrombospondin-related anonymous protein as assessed with transgenic Plasmodium berghei parasites.Rhesus macaque and mouse models for down-selecting circumsporozoite protein based malaria vaccines differ significantly in immunogenicity and functional outcomesEvaluation of Plasmodium vivax Cell-Traversal Protein for Ookinetes and Sporozoites as a Preerythrocytic P. vivax Vaccine.Plasmodium Sporozoite Biology.The use of transgenic parasites in malaria vaccine research.Development and Assessment of Transgenic Rodent Parasites for the Preclinical Evaluation of Malaria Vaccines.Vaccine Containing the Three Allelic Variants of the Plasmodium vivax Circumsporozoite Antigen Induces Protection in Mice after Challenge with a Transgenic Rodent Malaria Parasite.Repetitive sequences in malaria parasite proteins.Humoral protection against mosquito bite-transmitted Plasmodium falciparum infection in humanized mice.Comparative analysis of low complexity regions in Plasmodia.Synthesis and Evaluation of Antiplasmodial Efficacy of β-Carboline Derivatives against Murine Malaria
P2860
Q26781372-8F2EE9D6-D8BB-4E43-A05B-629D2711EF8EQ33572458-EBA61034-AFFD-4955-9DDC-829303F3443CQ34298647-B0FED1E7-ABFA-49D4-9A31-C39C70641819Q34600916-ACD0D821-D602-4A11-A1F9-DB9D0D0F46BFQ35561160-B8E94CA5-267E-4C3C-852E-EC2DC12E7F7FQ36024455-BECED853-6D9D-4AE7-8139-B8EDC044DBABQ36303403-AB46AFE6-2684-4C33-B31D-193D1BE6CCEAQ36853669-812AAB62-9366-4934-86C3-1BA8BBA25522Q37546314-EE9C0907-4E35-4EFB-9AEA-13472A0DF18DQ37643867-90347665-E37E-4223-8DDC-BC3666D582C2Q37696415-4031719A-726F-46F8-B839-FB15B9D9881EQ37739740-DE0C5DE7-83E6-4290-BC9B-F9A605610CBDQ38558444-48446DFE-DB62-4E0B-9F4A-848BDEA2F7F5Q39318510-6045BB4B-39E2-4381-BBBE-C7F3A12AAED0Q40715688-942BAC56-86E3-47E8-BD64-5EC229FD0896Q42699604-B18940AF-3736-47BB-9F56-18A8ECCB1664Q46273301-4D0AB3F7-18E5-4B68-9E11-BCA459E7543AQ47099112-3F1A971C-A870-42DB-8B78-4083FFA16F36Q48043737-BB0FD41B-598B-4804-AD85-91F2F3F90099Q58581156-DB2CB2D1-F9D9-4EE1-BE49-A703FD04F824
P2860
Development of a chimeric Plasmodium berghei strain expressing the repeat region of the P. vivax circumsporozoite protein for in vivo evaluation of vaccine efficacy.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 28 May 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Development of a chimeric Plas ...... valuation of vaccine efficacy.
@en
Development of a chimeric Plas ...... valuation of vaccine efficacy.
@nl
type
label
Development of a chimeric Plas ...... valuation of vaccine efficacy.
@en
Development of a chimeric Plas ...... valuation of vaccine efficacy.
@nl
prefLabel
Development of a chimeric Plas ...... valuation of vaccine efficacy.
@en
Development of a chimeric Plas ...... valuation of vaccine efficacy.
@nl
P2093
P2860
P356
P1476
Development of a chimeric Plas ...... valuation of vaccine efficacy.
@en
P2093
Anjali Yadava
Christian F Ockenhouse
Evelina Angov
Fidel Zavala
P2860
P304
P356
10.1128/IAI.00461-13
P407
P577
2013-05-28T00:00:00Z